talabostat [Ligand Id: 9892] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL67279 (PT-100, Talabostat, Valinyl-L-Boroproline)
  • Dipeptidyl-peptidase 7/Dipeptidyl peptidase II in Human [ChEMBL: CHEMBL3976] [GtoPdb: 1605] [UniProtKB: Q9UHL4]
There should be some charts here, you may need to enable JavaScript!
  • dipeptidyl peptidase 4/Dipeptidyl peptidase IV in Human [ChEMBL: CHEMBL284] [GtoPdb: 1612] [UniProtKB: P27487]
There should be some charts here, you may need to enable JavaScript!
  • dipeptidyl peptidase 9/Dipeptidyl peptidase IX in Human [ChEMBL: CHEMBL4793] [GtoPdb: 2357] [UniProtKB: Q86TI2]
There should be some charts here, you may need to enable JavaScript!
  • dipeptidyl peptidase 8/Dipeptidyl peptidase VIII in Human [ChEMBL: CHEMBL4657] [GtoPdb: 2356] [UniProtKB: Q6V1X1]
There should be some charts here, you may need to enable JavaScript!
  • fibroblast activation protein alpha/Fibroblast activation protein alpha in Human [ChEMBL: CHEMBL4683] [GtoPdb: 2365] [UniProtKB: Q12884]
There should be some charts here, you may need to enable JavaScript!
  • prolyl endopeptidase/Prolyl endopeptidase in Human [ChEMBL: CHEMBL3202] [GtoPdb: 2395] [UniProtKB: P48147]
There should be some charts here, you may need to enable JavaScript!
  • fibroblast activation protein alpha/Seprase in Mouse [ChEMBL: CHEMBL5769] [GtoPdb: 2365] [UniProtKB: P97321]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
Dipeptidyl-peptidase 7/Dipeptidyl peptidase II in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3976] [GtoPdb: 1605] [UniProtKB: Q9UHL4]
ChEMBL Inhibitory activity of compound against Dipeptidylpeptidase II (DPP II) B 3.9 pKi 125000 nM Ki J Med Chem (2003) 46: 5005-5014 [PMID:14584950]
ChEMBL Inhibition of Dipeptidyl Peptidase II (Quiescent cell proline peptidase) B 6.9 pKi 125 nM Ki Bioorg Med Chem Lett (2002) 12: 2825-2828 [PMID:12270155]
ChEMBL Inhibition of quiescent cell proline dipeptidase (QPP) B 6.9 pKi 125 nM Ki J Med Chem (2004) 47: 4135-4141 [PMID:15293982]
ChEMBL Inhibition of DPP2 in human seminal plasma using Lys-Ala-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition B 7.07 pIC50 86 nM IC50 ACS Med Chem Lett (2013) 4: 491-496 [PMID:24900696]
ChEMBL Binding affinity to DPP2 (unknown origin) B 7.07 pIC50 86 nM IC50 Medchemcomm (2014) 5: 1700-1707
ChEMBL Inhibition of DPP2 (unknown origin) using AMC substrate by fluorometric assay B 7.07 pIC50 86 nM IC50 Bioorg Med Chem Lett (2021) 37: 127846-127846 [PMID:33571650]
ChEMBL Inhibition of human seminal plasma DPP2 assessed as pNA release from Lys-Ala-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique B 7.07 pIC50 86 nM IC50 Bioorg Med Chem Lett (2012) 22: 3412-3417 [PMID:22525314]
ChEMBL Inhibition of DPP2 purified from human seminal plasma using Lys-Ala-p-nitroanilide as substrate by spectrophotometry B 7.07 pIC50 86 nM IC50 J Med Chem (2014) 57: 3053-3074 [PMID:24617858]
ChEMBL Inhibition of human DPP2 B 7.52 pIC50 30 nM IC50 Bioorg Med Chem Lett (2007) 17: 507-510 [PMID:17055271]
ChEMBL Compound was tested in vitro for inhibition of Dipeptidylpeptidase II B 7.82 pIC50 15 nM IC50 J Med Chem (1996) 39: 2087-2094 [PMID:8642568]
dipeptidyl peptidase 4/Dipeptidyl peptidase IV in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL284] [GtoPdb: 1612] [UniProtKB: P27487]
ChEMBL Inhibitory activity of compound against Dipeptidylpeptidase IV (DPP IV) B 5.7 pKi 2000 nM Ki J Med Chem (2003) 46: 5005-5014 [PMID:14584950]
ChEMBL Inhibition of Dipeptidyl Peptidase IV B 8.7 pKi 2 nM Ki Bioorg Med Chem Lett (2002) 12: 2825-2828 [PMID:12270155]
ChEMBL Binding affinity for dipeptidylpeptidase IV B 8.7 pKi 2 nM Ki J Med Chem (2004) 47: 4135-4141 [PMID:15293982]
GtoPdb - - 9.74 pKi 0.18 nM Ki J Med Chem (2008) 51: 6005-13 [PMID:18783201]
ChEMBL Inhibition of human placental DPP4 B 9.74 pKi 0.18 nM Ki J Med Chem (2007) 50: 2391-2398 [PMID:17458948]
ChEMBL Inhibition of human placental DPP4 B 9.74 pKi 0.18 nM Ki J Med Chem (2008) 51: 6005-6013 [PMID:18783201]
ChEMBL Binding affinity to DPP-4 (unknown origin) assessed as inhibition constant B 9.74 pKi 0.18 nM Ki Bioorg Med Chem (2022) 63: 116748-116748 [PMID:35453036]
ChEMBL Inhibition of human placental DPP4 at pH 8 B 5.92 pIC50 1200 nM IC50 J Med Chem (2007) 50: 2391-2398 [PMID:17458948]
ChEMBL Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 ÎĽL sample of this solution is then added to 990 ÎĽL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 ÎĽL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 ÎĽL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 ÎĽL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5). B 5.92 pIC50 1200 nM IC50 US-8933056-B2. Soft protease inhibitors and pro-soft forms thereof (2015)
ChEMBL Inhibition of DDP4 at pH 7.4 preincubated for 10 mins B 6.33 pIC50 470 nM IC50 J Med Chem (2011) 54: 2022-2028 [PMID:21388136]
ChEMBL In vitro for inhibition of Dipeptidylpeptidase IV. B 7.59 pIC50 26 nM IC50 J Med Chem (1996) 39: 2087-2094 [PMID:8642568]
ChEMBL Inhibition of DPP4 (unknown origin) B 7.66 pIC50 22 nM IC50 Eur J Med Chem (2022) 240: 114543-114543 [PMID:35797897]
ChEMBL Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition B 7.66 pIC50 22 nM IC50 ACS Med Chem Lett (2013) 4: 491-496 [PMID:24900696]
ChEMBL Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry B 7.66 pIC50 22 nM IC50 J Med Chem (2014) 57: 3053-3074 [PMID:24617858]
ChEMBL Binding affinity to DPP4 (unknown origin) B 7.66 pIC50 22 nM IC50 Medchemcomm (2014) 5: 1700-1707
ChEMBL Inhibition of DPP4 (unknown origin) B 7.66 pIC50 22 nM IC50 J Med Chem (2019) 62: 7874-7884 [PMID:31393718]
ChEMBL Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay B 7.66 pIC50 22 nM IC50 Bioorg Med Chem Lett (2021) 37: 127846-127846 [PMID:33571650]
ChEMBL Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique B 7.66 pIC50 22 nM IC50 Bioorg Med Chem Lett (2012) 22: 3412-3417 [PMID:22525314]
ChEMBL Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 ÎĽL sample of this solution is then added to 990 ÎĽL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 ÎĽL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 ÎĽL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 ÎĽL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5). B 8.77 pIC50 1.7 nM IC50 US-8933056-B2. Soft protease inhibitors and pro-soft forms thereof (2015)
ChEMBL Inhibition of human placental DPP4 at pH 2 B 8.8 pIC50 1.6 nM IC50 J Med Chem (2007) 50: 2391-2398 [PMID:17458948]
ChEMBL Inhibition of DDP4 at pH 2 preincubated for 10 mins B 8.82 pIC50 1.5 nM IC50 J Med Chem (2011) 54: 2022-2028 [PMID:21388136]
ChEMBL Inhibition of human DPP4 using H-Gly-Pro-AMC as substrate preincubated for 10 mins prior to substrate addition by fluorescence assay B 9.05 pIC50 0.9 nM IC50 J Med Chem (2013) 56: 3467-3477 [PMID:23594271]
ChEMBL Inhibition of human DPP4 B 10 pIC50 0.1 nM IC50 Bioorg Med Chem Lett (2007) 17: 507-510 [PMID:17055271]
dipeptidyl peptidase 9/Dipeptidyl peptidase IX in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4793] [GtoPdb: 2357] [UniProtKB: Q86TI2]
ChEMBL Inhibition of human recombinant DPP9 expressed in HEK293T cells B 9.12 pKi 0.76 nM Ki J Med Chem (2008) 51: 6005-6013 [PMID:18783201]
GtoPdb - - 9.12 pKi 0.76 nM Ki J Med Chem (2008) 51: 6005-13 [PMID:18783201]
ChEMBL Inhibition of human recombinant DPP9 expressed in intact HEK293T cells after 2 hrs B 5.17 pIC50 6800 nM IC50 J Med Chem (2008) 51: 6005-6013 [PMID:18783201]
ChEMBL Inhibition of human DPP9 using H-Gly-Pro-AMC as substrate preincubated for 10 mins prior to substrate addition by fluorescence assay B 8.66 pIC50 2.2 nM IC50 J Med Chem (2013) 56: 3467-3477 [PMID:23594271]
ChEMBL Inhibition of human DPP9 B 8.7 pIC50 2 nM IC50 Bioorg Med Chem Lett (2007) 17: 507-510 [PMID:17055271]
dipeptidyl peptidase 8/Dipeptidyl peptidase VIII in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4657] [GtoPdb: 2356] [UniProtKB: Q6V1X1]
GtoPdb - - 8.82 pKi 1.5 nM Ki J Med Chem (2008) 51: 6005-13 [PMID:18783201]
ChEMBL Inhibition of human recombinant DPP8 expressed in HEK293T cells B 8.82 pKi 1.5 nM Ki J Med Chem (2008) 51: 6005-6013 [PMID:18783201]
ChEMBL Inhibition of human DPP8 B 7.77 pIC50 17 nM IC50 Bioorg Med Chem Lett (2007) 17: 507-510 [PMID:17055271]
ChEMBL Inhibition of human DPP8 using H-Gly-Pro-AMC as substrate preincubated for 10 mins prior to substrate addition by fluorescence assay B 8.26 pIC50 5.5 nM IC50 J Med Chem (2013) 56: 3467-3477 [PMID:23594271]
fibroblast activation protein alpha/Fibroblast activation protein alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4683] [GtoPdb: 2365] [UniProtKB: Q12884]
ChEMBL Inhibition of FAP (unknown origin) B 7.18 pKi 66 nM Ki Eur J Med Chem (2022) 240: 114543-114543 [PMID:35797897]
ChEMBL Binding affinity to FAP (unknown origin) assessed as inhibition constant B 8.3 pKi 5 nM Ki Bioorg Med Chem (2022) 63: 116748-116748 [PMID:35453036]
ChEMBL Inhibition of FAP in human U87MG cells using Suc-Gly-Pro-AMC as substrate by fluorescence based assay B 6.65 pIC50 224 nM IC50 Bioorg Med Chem Lett (2020) 30: 127253-127253 [PMID:32527554]
ChEMBL Binding affinity to FAP (unknown origin) B 7.15 pIC50 70 nM IC50 Medchemcomm (2014) 5: 1700-1707
ChEMBL Inhibition of FAP (unknown origin) using AMC substrate by fluorometric assay B 7.15 pIC50 70 nM IC50 Bioorg Med Chem Lett (2021) 37: 127846-127846 [PMID:33571650]
ChEMBL Inhibition of FAP (unknown origin) B 7.18 pIC50 66 nM IC50 J Med Chem (2019) 62: 7874-7884 [PMID:31393718]
ChEMBL Inhibition of human FAP B 7.62 pIC50 24 nM IC50 Bioorg Med Chem Lett (2007) 17: 507-510 [PMID:17055271]
ChEMBL Inhibition of human FAP using Z-Gly-Pro-AMC as substrate preincubated for 10 mins prior to substrate addition by fluorescence assay B 7.92 pIC50 12 nM IC50 J Med Chem (2013) 56: 3467-3477 [PMID:23594271]
prolyl endopeptidase/Prolyl endopeptidase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3202] [GtoPdb: 2395] [UniProtKB: P48147]
ChEMBL Compound was tested in vitro for inhibition of Prolyl endopeptidase B 4.64 pIC50 23000 nM IC50 J Med Chem (1996) 39: 2087-2094 [PMID:8642568]
ChEMBL Inhibition of prolyl oligopeptidase B 5.1 pIC50 7960 nM IC50 Bioorg Med Chem Lett (2007) 17: 507-510 [PMID:17055271]
ChEMBL Inhibition of human recombinant PREP expressed in Escherichia coli using Z-Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition B 6.01 pIC50 980 nM IC50 ACS Med Chem Lett (2013) 4: 491-496 [PMID:24900696]
ChEMBL Inhibition of recombinant human PREP purified from Escherichia coli using Z-Gly-Pro-p-nitroanilide as substrate by spectrophotometry B 6.01 pIC50 980 nM IC50 J Med Chem (2014) 57: 3053-3074 [PMID:24617858]
ChEMBL Binding affinity to PREP (unknown origin) B 6.01 pIC50 980 nM IC50 Medchemcomm (2014) 5: 1700-1707
ChEMBL Inhibition of POP (unknown origin) B 6.01 pIC50 980 nM IC50 J Med Chem (2019) 62: 7874-7884 [PMID:31393718]
ChEMBL Inhibition of PREP (unknown origin) using AMC substrate by fluorometric assay B 6.01 pIC50 980 nM IC50 Bioorg Med Chem Lett (2021) 37: 127846-127846 [PMID:33571650]
ChEMBL Inhibition of human recombinant PREP expressed in Escherichia coli assessed as pNA release from Z-Gly-Pro-p-nitroanilide pre-incubated with enzyme for 15 mins prior to substrate addition by fluorescence technique B 6.01 pIC50 980 nM IC50 Bioorg Med Chem Lett (2012) 22: 3412-3417 [PMID:22525314]
ChEMBL Inhibition of human PREP using Z-Gly-Pro-AMC as substrate preincubated for 10 mins prior to substrate addition by fluorescence assay B 7.14 pIC50 73 nM IC50 J Med Chem (2013) 56: 3467-3477 [PMID:23594271]
fibroblast activation protein alpha/Seprase in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5769] [GtoPdb: 2365] [UniProtKB: P97321]
ChEMBL Inhibition of mouse recombinant FAP expressed in HEK293 cells using Ala-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition B 7.15 pIC50 70 nM IC50 ACS Med Chem Lett (2013) 4: 491-496 [PMID:24900696]
ChEMBL Inhibition of mouse recombinant FAP expressed in HEK293 cells assessed as pNA release from Ala-Pro-p-nitroanilide pre-incubated with enzyme for 15 mins prior to substrate addition by fluorescence technique B 7.18 pIC50 66 nM IC50 Bioorg Med Chem Lett (2012) 22: 3412-3417 [PMID:22525314]
ChEMBL Inhibition of recombinant mouse FAP purified from HEK293 cell supernatant using Ala-Pro-p-nitroanilide as substrate by spectrophotometry B 7.18 pIC50 66 nM IC50 J Med Chem (2014) 57: 3053-3074 [PMID:24617858]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]